These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3565455)

  • 1. A comparison of native and modified intravenous immunoglobulin for the management of hypogammaglobulinemia.
    Steele RW; Augustine RA; Steele RW; Tannenbaum AS; Charlton RK
    Am J Med Sci; 1987 Feb; 293(2):69-74. PubMed ID: 3565455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immune globulin for hypogammaglobulinemia: a comparison of opsonizing capacity in recipient sera.
    Steele RW; Augustine RA; Tannenbaum AS; Marmer DJ
    Clin Immunol Immunopathol; 1985 Mar; 34(3):275-83. PubMed ID: 3971602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early intravenous immunoglobulin replacement in hypogammaglobulinemic heart transplant recipients: results of a clinical trial.
    Sarmiento E; Diez P; Arraya M; Jaramillo M; Calahorra L; Fernandez-Yañez J; Palomo J; Sousa I; Hortal J; Barrio J; Alonso R; Muñoz P; Navarro J; Vicario J; Fernandez-Cruz E; Carbone J
    Transpl Infect Dis; 2016 Dec; 18(6):832-843. PubMed ID: 27639067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of low-dose intravenous immunoglobulin as the adjunctive therapy in septic shock patients with and without hypogammaglobulinemia: a retrospective cohort study.
    Goto K; Yasuda N; Sato Y
    Ann Palliat Med; 2022 Aug; 11(8):2600-2608. PubMed ID: 35695053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Build-up maintenance of IgG serum concentrations with intravenous immunoglobulin in patients with primary humoral immunodeficiency.
    Morell A; Schnoz M; Barandun S
    Vox Sang; 1982; 43(4):212-9. PubMed ID: 7135889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin for hypogammaglobulinemia after lung transplantation: a randomized crossover trial.
    Lederer DJ; Philip N; Rybak D; Arcasoy SM; Kawut SM
    PLoS One; 2014; 9(8):e103908. PubMed ID: 25090414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial.
    Eijkhout HW; van Der Meer JW; Kallenberg CG; Weening RS; van Dissel JT; Sanders LA; Strengers PF; Nienhuis H; Schellekens PT;
    Ann Intern Med; 2001 Aug; 135(3):165-74. PubMed ID: 11487483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient hypogammaglobulinemia of infancy: intravenous immunoglobulin as first line therapy.
    Duse M; Iacobini M; Leonardi L; Smacchia P; Antonetti L; Giancane G
    Int J Immunopathol Pharmacol; 2010; 23(1):349-53. PubMed ID: 20378022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin dosage and switch from intravenous to subcutaneous immunoglobulin replacement therapy in patients with primary hypogammaglobulinemia: decreasing dosage does not alter serum IgG levels.
    Thépot S; Malphettes M; Gardeur A; Galicier L; Asli B; Karlin L; Gérard L; Laumont R; Doize ML; Arnulf B; Fieschi C; Bengoufa D; Oksenhendler E
    J Clin Immunol; 2010 Jul; 30(4):602-6. PubMed ID: 20393788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypogammaglobulinemia in pediatric liver transplant recipients.
    Ganschow R; Englert C; Grabhorn E; Richter A; Hinrichs B; Broering DC; Rogiers X; Burdelski M
    Pediatr Transplant; 2005 Apr; 9(2):215-9. PubMed ID: 15787796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypogammaglobulinemia after heart transplantation: use of intravenous immunoglobulin replacement therapy in relapsing CMV disease.
    Sarmiento E; Fernàndez-Yáñez J; Muñoz P; Palomo J; Rodríguez-Molina JJ; Bermejo J; Catalan P; Bouza E; Fernández-Cruz E; Carbone J
    Int Immunopharmacol; 2005 Jan; 5(1):97-101. PubMed ID: 15589466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in biochemical, hematological and immunological profiles after low-dose intravenous immunoglobulin administration in patients with hypogammaglobulinemia.
    Berlana D; Vidaller A; Jódar R; Fort E; Domingo A; Pastó L
    Transfus Clin Biol; 2005 Dec; 12(6):433-40. PubMed ID: 16616571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tolerability and pharmacokinetics of an intravenous immunoglobulin preparation in immunologically normal subjects and tolerability in patients with hypogammaglobulinemia resulting from chronic lymphatic leukemia].
    Huser HJ; Schwander D; Wegmann A; Chariatte N; Fässler MA
    Schweiz Med Wochenschr; 1986 Feb; 116(5):151-6. PubMed ID: 3515530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravenous and subcutaneous immunoglobulin therapy].
    Thon V
    Epidemiol Mikrobiol Imunol; 2013 Jul; 62(2):64-73. PubMed ID: 23964967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial Serum Immunoglobulin G (IgG) Trough Levels in Patients with X-linked Agammaglobulinemia on Replacement Therapy with Intravenous Immunoglobulin: Its Correlation with Infections in Indian Children.
    Suri D; Bhattad S; Sharma A; Gupta A; Rawat A; Sehgal S; Singh S; Gupta S
    J Clin Immunol; 2017 Apr; 37(3):311-318. PubMed ID: 28321612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous versus subcutaneous immunoglobulin replacement in secondary hypogammaglobulinemia.
    Spadaro G; Pecoraro A; De Renzo A; Della Pepa R; Genovese A
    Clin Immunol; 2016 May; 166-167():103-4. PubMed ID: 27063866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentrations of immunoglobulins and of antibody isotypes in bone marrow transplant recipients treated with high doses of polyspecific immunoglobulin or with cytomegalovirus hyperimmune globulin.
    Gratwohl A; Doran JE; Bachmann P; Scherz R; Späth P; Baumgartner C; Perret B; Berger C; Nissen C; Tichelli A
    Bone Marrow Transplant; 1991 Oct; 8(4):275-82. PubMed ID: 1661632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of immunoglobulin preparations for intravenous use.
    Barandun S; Isliker H
    Vox Sang; 1986; 51(2):157-60. PubMed ID: 3535252
    [No Abstract]   [Full Text] [Related]  

  • 19. Restoration of humoral immunity after intravenous immunoglobulin replacement therapy in heart recipients with post-transplant antibody deficiency and severe infections.
    Carbone J; Sarmiento E; Del Pozo N; Rodriguez-Molina JJ; Navarro J; Fernandez-Yañez J; Palomo J; Villa A; Muñoz P; Fernandez-Cruz E
    Clin Transplant; 2012; 26(3):E277-83. PubMed ID: 22686951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of antigen-specific antibody following administration of intravenous immunoglobulin in patients with primary immunodeficiency diseases.
    Fischer SH; Ochs HD; Wedgwood RJ; Skvaril F; Morell A; Hill HR; Schiffmann G; Corey L
    Monogr Allergy; 1988; 23():225-35. PubMed ID: 3386642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.